
|Videos|August 27, 2015
What Pharmacists Should Know About Afrezza
Jessica Kerr, PharmD, CDE, assistant department chair at Southern Illinois University Edwardsville, discusses what pharmacists should know about Afrezza.
Advertisement
Jessica Kerr, PharmD, CDE, assistant department chair at Southern Illinois University Edwardsville, discusses what pharmacists should know about Afrezza.
This video was filmed at CHPC 2015.
Newsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Pharmacy Times
1
Abemaciclib Provides Long-Term Survival Benefit in High-Risk Early Breast Cancer
2
Five-Year NATALEE Data Show Ribociclib Improves Outcomes in High-Risk HR+/HER2– Early Breast Cancer
3
Durvalumab Plus Chemotherapy Sets New Standard in Resectable Gastric and GEJ Cancer
4
TAR-200 Intravesical System Demonstrates Sustained Bladder Exposure in BCG-Unresponsive NMIBC
5